Review
Open access
Jul 2026
Targeted nanomedicine strategies for Alzheimer’s disease therapy
This review synthesizes recent nanomedicine strategies that aim to bridge the gap between biomarker-oriented nanosensors and imaging probes for earlier detection with targeted nanocarriers designed to overcome delivery barriers, particularly the blood–brain barrier, while improving pharmacokinetics and limiting off-target exposure.
M. Ardah, Baraa Mohammed Yaseen, H. Malathi et al.
· Discover Nano · 2 citations